Literature DB >> 201958

The role of oestrogen replacement in the climacteric syndrome.

R C Strickler, R Borth, A Cecutti, B A Cookson, J A Harper, R Potvin, P Riffel, V J Sorbara, C A Woolever.   

Abstract

Using a double-blind placebo-controlled cross-over design, the effect of equine conjugated oestrogens tablets (Premarin) was studied in 20 women with the climacteric syndrome followed during 15 months. Sixteen women were equally improved on placebo and oestrogen. Only 2 patients had an improved sense of well-being on oestrogen and not on placebo. The psychological diagnosis was unrelated to the subjective response to oestrogen or placebo. Performance in psychological tests administered before and during treatment periods was not changed by oestrogen or placebo.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 201958     DOI: 10.1017/s0033291700006280

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  14 in total

1.  Neurobiological Underpinnings of the Estrogen - Mood Relationship.

Authors:  Whitney Wharton; Carey E Gleason; Sandra R M S Olson; Cynthia M Carlsson; Sanjay Asthana
Journal:  Curr Psychiatry Rev       Date:  2012-08-01

2.  Hormone replacement therapy: knowledge, attitudes, and well-being among middle-aged Australian women.

Authors:  K France; C Lee; M Schofield
Journal:  Int J Behav Med       Date:  1996

3.  Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression.

Authors:  B Saletu; N Brandstätter; M Metka; M Stamenkovic; P Anderer; H V Semlitsch; G Heytmanek; J Huber; J Grünberger; L Linzmayer
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

4.  The menopausal hot flush: symptom reports and concomitant physiological changes.

Authors:  L C Swartzman; R Edelberg; E Kemmann
Journal:  J Behav Med       Date:  1990-02

Review 5.  Estrogen action in mood and neurodegenerative disorders: estrogenic compounds with selective properties-the next generation of therapeutics.

Authors:  Marie K Osterlund; Michael-Robin Witt; Jan-Ake Gustafsson
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

Review 6.  Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes.

Authors:  A H Maclennan; J L Broadbent; S Lester; V Moore
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

Review 7.  Role of estrogen in the aetiology and treatment of mood disorders.

Authors:  U Halbreich; L S Kahn
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 8.  Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause.

Authors:  Claudio N Soares; Jennifer R Poitras; Jennifer Prouty
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  Menopausal syndrome: illness or social role--a transcultural analysis.

Authors:  J M Townsend; C L Carbone
Journal:  Cult Med Psychiatry       Date:  1980-09

Review 10.  The other side of estrogen replacement therapy: outcome study results of mood improvement in estrogen users and nonusers.

Authors:  Karen J Miller
Journal:  Curr Psychiatry Rep       Date:  2003-12       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.